Effect of GH and insulin on the generation of somatomedin by perfused rat liver.
スポンサーリンク
概要
- 論文の詳細を見る
The release of somatomedin from perfused livers of normal and hypophysectomized (hypox) rats has been studied. Somatomedin was determined by the radioreceptor assay for somatomedin A. The release of somatomedin in the perfusates of normal livers was observed during the initial 30minutes and maintained during the second and third 30 minutes of recirculation. The addition of insulin at a concentration of 10mU/ml to the perfusates caused a significant increase in the release of somatomedin in the 1st, 2nd and 3rd 30-minute recirculatory perfusates. The addition of human growth hormone (25μg/ml) and/or insulin (1mU/ml) to the perfusates caused a significant increase in somatomedin after 120minutes of recirculation. Hypox rats released amounts of somatomedin in perfusates similar to those of normal rats. The effect of insulin on the release of somatomedin was greater in hypox rats than that observed in normal rats.<BR>The molecular size of the somatomedin released in the perfusate was greater than that of purified somatomedin, suggesting that this somatomedin is bound to carrier proteins.
- 社団法人 日本内分泌学会の論文
著者
-
Takano Kazue
Department Of Endocrinology Clinical Institute Of Endocrinology Tokyo Women's Medical Universit
-
Asakawa Kumiko
Department Of Medicine Institute Of Clinical Endocrinology Tokyo Women's College
-
SHIZUME KAZUO
Department of Endocrinology and Endocrine Research Laboratory Toranomon Hospital
-
HIZUKA NAOMI
Department of Internal Medicine Tokyo Women's Medical College
-
KOGAWA MEGUMI
Department of Medicine Tokyo Women's Medical College
関連論文
- 腸腰筋膿瘍を合併したACTH依存性Cushing症候群の疑い例
- プロラクチノーマの新規内分泌診断法の開発と自験450症例のCabergoline治療成績(間脳下垂体腫瘍の治療)
- 挙児希望女性に発生したホルモン産生下垂体腺腫への対応(妊娠分娩と脳神経外科疾患)
- 維持量の活性型ビタミンD(1α-OHD3)を内服中にintact PTH抑制が不十分な高カルシウム血症クリーゼを呈した骨粗鬆症患者の一例
- カテコラミン過剰症による麻痺性イレウスに非選択的α受容体遮断薬が有効であった悪性褐色細胞腫の一例
- Euthyroid Graves' disease患者血清より得られたIgGのヒト甲状腺濾胞浮遊培養系における甲状腺ホルモン分泌刺激活性
- 集中治療室・重症疾患における副腎不全の診断 (特集 副腎不全とステロイド補充療法)
- 内分泌性高血圧症 レニン産生腫瘍 (高血圧(第4版)--日本における最新の研究動向(下)) -- (二次性高血圧の治療)
- Insulinoma with Six Islet Cell Tumors Associated with Severe Hypoglycemia
- バセドウ病に対する放射性ヨード(^I)治療施行前の適切なヨード制限期間